Why muscle mass is just as important for people taking GLP-1 weight loss pills
Doctors are issuing a warning for people taking GLP-1 weight loss pills.
Watch CBS News
Doctors are issuing a warning for people taking GLP-1 weight loss pills.
Popular weight loss drugs such as Ozempic and Wegovy could prevent breast cancer, preliminary research from Penn Medicine shows. Reporter Stephanie Stahl talked to the lead researcher about the study.
Wellness tourism is booming around the world as travelers look for opportunities to lose weight and detox at home and abroad.
Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.
The popularity of GLP-1 weight loss drugs might be expanding to our pets. New research is underway for something being called "ozem-pets." Health reporter Stephanie Stahl has more on the research.
Research shows that some people are thinking about skipping their weight loss medication for the holiday, but doctors say that's not a good idea.
President Trump on Thursday announced a deal to drastically lower the price of weight loss drugs for some Americans.
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
A growing number of people are taking weight loss drugs. While they work for most people, results tend to vary. This research indicates that could be because of a person's family history.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can also cause problems. Now that millions of people have successfully lost weight using them, many are wondering about quitting. Stephanie Stahl has one dieter’s journey, being told on Instagram.
Popular weight loss drugs like Ozempic might be able to help with substance abuse, according to new research.
Brandon Downey, a New Jersey nurse, said the drug Wegovy has helped him lose weight and overcome an alcohol addiction.
A growing number of weight loss patients are turning to cosmetic procedures to restore sagging skin on the face. It's a new trend. The issue is often called Ozempic face when people lose a lot of weight the skin on the face can lose volume. Stephanie Stahl reports.
The high price of some popular weight loss drugs is at the center of a congressional committee on Tuesday with a pharmaceutical executive in the hot seat. Stephanie Stahl reports more on the price concerns.
Incorrect dose calculations have resulted in patients administering 5 to 10 times more of the medication than drugmakers intended.
A hearing is scheduled Thursday for a U.S. district judge to decide how the cases proceed. It's the beginning of what many say will probably be a long drawn-out legal fight.
Oprah Winfrey is donating her shares in WeightWatchers and stepping down from the board, another blow to weight-loss companies that have struggled with the rise of drugs like Wegovy and Ozempic - which Oprah said she uses, though she has not named one specifically.
Every week on Health Watch we look at topics that impact our viewers and their wellbeing. In this week's episode, we're talking about the measles threat that is growing and health experts tell us why at least a third of the U.S. is at risk.
When diet and exercise aren't enough, doctors say some people need medical treatments to lose weight and they're concerned about diet shaming.
From the Ozempic "ripple effect" to health tech and more, experts share their predictions for 2024 wellness trends.
The FDA and drugmaker Novo Nordisk are working to identify thousands of counterfeit Ozempic drugs seized in an ongoing investigation.
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
New research says these drugs can cause serious, even deadly side effects.
After three months, all 10 patients of the study were able to stop taking prandial insulin.
